Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analog AN-152 in androgen sensitive and insensitive prostate cancers. - Letsch,M.; Schally,AV.; Szepeshazi,K.; Halmos,G.; Nagy,A. (Clin Cancer Res, 2003)